Beauty Health Co(SKIN)

upturn advisory logo
ADVISORIES YOU CAN VERIFY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$0.7
09/14/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close

Advisory Performance History (Simulated)Advisory Performance History info

Upturn Advisory & Investor View for SKIN

09/14/2026: SKIN (1-star) is currently NOT-A-BUY. Pass it for now.

The Beauty Health Company (SKIN) is a player in the medical aesthetics market, best known for its proprietary HydraFacial platform. Its business model relies on a 'razor-and-blade' strategy, which generates steady recurring revenue from consumable tips and serums used in treatments. The primary investment story centers on the global expansion of its skin health brand and increased treatment adoption. Risks include intense competition from other device manufacturers, sensitivity to elective consumer spending, and the ongoing challenge of achieving consistent profitability. The stock is generally suited for growth-oriented investors who monitor the company's ability to maintain high margins while effectively scaling its international installed base.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitThe company operates in a high-growth sector but faces execution and profitability hurdles that temper pure growth expectations.
Momentum investorWeak fitMomentum investors may find the current stock performance lacking a consistent positive upturn signal.
Value investorMixed fitThe valuation may look attractive to some, but fundamental stability is required to justify a value-based entry.
Dividend investorWeak fitThe company does not pay a dividend and focuses on reinvesting cash into the business.
Low-risk investorWeak fitThe company's volatility and reliance on discretionary consumer spending make it unsuitable for risk-averse investors.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock has experienced significant fluctuations related to sector sentiment and company-specific operational news.
Valuation riskMediumMarket expectations for growth must be consistently met to maintain current valuation levels.
Competition risk (Aesthetic Device competition)Medium / highThe sector is increasingly crowded, and the company must defend its HydraFacial market share against both established and new players.
Business qualityMediumWhile the razor-and-blade model is strong, operational consistency and profitability are still being proven.
Dividend incomeLow / noneThe company does not provide income through dividends.
Execution riskMedium / highSuccessful scaling depends on effective global sales management and maintaining relationships with aesthetic providers.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -62.24%
Avg. Invested days 22
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 09/14/2026

Upturn Scorecard

Upturn Star Rating

SKIN receives a 3-star rating, supported by solid company fundamentals. The rating is constrained by soft unit economics, soft quantitative characteristics, and weak price momentum.

Company Fundamentals

SKIN has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+67.3%) and solid cash generation (FCF margin 10.7%) are partially offset by negative revenue growth (-10.0%), soft profitability (net margin -3.2%).

Financial Health Rating

SKIN's financial health is supported by solid liquidity, including working-capital and asset support (WC/assets 24.7%). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

Free-cash-flow growth is SKIN's strongest growth driver at +246.1% FY2025 versus FY2024 (strong, 5 stars). By comparison, earnings growth (+67.3%, strong) is also strong, while revenue growth (-10.0%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

Institutional ownership is 77.2% and approximately 42.8% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 13.03% supports management-shareholder alignment.

Top 5 Institutional Investors

Capricorn Fund Managers Ltd 17.12%
FMR Inc 13.20%
Millennium Management LLC 5.79%
BlackRock Inc 5.65%
Woodline Partners LP 4.38%

Unit Economics (Per $1K Revenue)

SKIN generates approximately $653 of gross profit, $-69 of operating income, and $107 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Strong cash conversion and healthy margins support the rating, although capital efficiency remains below the highest tier.

Economic Dimensions

Effective Tax Rate: -60.31% (Tax Credit)

Quantitative Style Profile

SKIN has a Value-Oriented profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedSmall / Mid Cap RiskShort Squeeze Risk

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 91.10M USD
Price to earnings Ratio -
1Y Target Price 0.99
Price to earnings Ratio -
1Y Target Price 0.99
Volume (30-day avg) 387.6K shares
Beta 1
52 Weeks Range 0.55 - 2.56
Updated Date 09/13/2026
52 Weeks Range 0.55 - 2.56
Updated Date 09/13/2026
Dividends yield (FY) -
Basic EPS (TTM) -0.23

How Company Makes Money

Business areaWhat it includesRetail investor read
HydraFacial SystemsSale of proprietary HydraFacial hardware units to providers.Revenue from the initial sale of equipment that establishes the customer relationship.
Consumables and ServicesSales of patented tips, serums, and booster treatments required for each session.This is the core, recurring revenue driver that fuels long-term margin potential.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Advertisement

Valuation

Trailing PE -
Forward PE 106.38
Enterprise Value 252.07M
Price to Sales(TTM) 0.31
Enterprise Value 252.07M
Price to Sales(TTM) 0.31
Enterprise Value to Revenue 0.87
Enterprise Value to EBITDA 9.7
Shares Outstanding 130.14M
Shares Floating 55.73M
Shares Outstanding 130.14M
Shares Floating 55.73M
Percent Insiders 13.03
Percent Institutions 77.19

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI Summary

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

About Beauty Health Co

Exchange NASDAQ
Headquarters Long Beach, CA, United States
IPO Launch date 2020-11-24
CEO, President & Director Mr. Pedro Malha
Sector Consumer Defensive
Industry Household & Personal Products
Full time employees 613
Full time employees 613

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.